Standard immunostains for melanoma in sentinel lymph node specimens: Which ones are most useful?

Journal of the American Academy of Dermatology

Volumn 50, Issue 5, 2004, Pages 759-764

  Karimipour, Darius J ^a,b,c   Lowe, Lori ^a,b   Su, Lyndon ^a,b   Hamilton, Ted ^a,b   Sondak, Vernon ^a,b   Johnson, Timothy M ^a,b   Fullen, Douglas ^a,b  

^a Univ of Michigan Medical Center ^*

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; HMB 45 ANTIGEN; MELAN A; MELANOMA ANTIGEN; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; UNCLASSIFIED DRUG;

ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 2342489448     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.07.016     Document Type: Article

References (33)

1. McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001;19:2851-5.
2. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng C, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-83.
3. Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, Lee JJ, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
4. Yu LL, Flotte TJ, Tanabe KK, Gadd MA, Cosimi AB, Sober AJ, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86:617-27.
5. Vaggelli L, Castagnoli A, Borgognoni L, Urso C, Matteini M, Cesco P. Radioisotopic lymphatic mapping of the sentinel node in melanoma: importance of immunohistochemistry. Tumori 2000;86:346-8.
6. Messina JL, Glass LF, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 1999;23:686-90.
7. Cochran AJ. The pathologist's role in sentinel lymph node evaluation. Semin Nucl Med 2000;30:11-7.
8. Li W, Stall A, Shivers SC, Lin J, Haddad F, Messina J, et al. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg 2000;231:795-803.
9. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998;280:1410-5.
10. Blaheta HJ, Schittek B, Breuninger H, Sotlar K, Ellwanger U, Thelen MH, et al. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999;23:822-8.
11. Palmieri G, Ascierto PA, Cossu A, Mozzillo N, Motti ML, Satriano SM, et al. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 2001;19:1437-43.
12. Blaheta HJ, Sotlar K, Breuninger H, Bueltmann B, Rassner G, Garbe C, et al. Does intensive histopathological workup by serial sectioning increase the detection of lymph node micrometastasis in patients with primary cutaneous melanoma? Melanoma Res 2001;11:57-63.
13. Carson KF, Wen DR, Li PX, Lana A, Bailly C, Morton DL, et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834-40.
14. Biddle DA, Evans HL, Kemp BL, El-Naggar AK, Harvell JD, White WL. Intraparenchymal nevus cell aggregates in lymph nodes. Am J Surg Path 2003;57:673-81.
15. Colombari R, Bonetti F, Zamboni G, Scarpa A, Marino F, Tomezzoli A, et al. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumors: an immunohistochemical study on paraffin sections. Virchows Arch A Path Anat Histopathol 1988;413:17-24.
16. Rodrigues LK, Leong SP, Kashani-Sabet M, Wong JH. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol 2001;45:303-8.
17. Fukui Y, Yamakawa T, Taniki T, Numoto S, Miki H, Monden Y. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001;92:2868-74.
18. Schmidt FE, Woltering EA, Webb WR, Garcia OM, Cohen JE, Rozans MH. Sentinel nodal assessment in patients with carcinoma of the lung. Ann Thorac Surg 2002;74:870-4.
19. Pittman KT, Johnson JT, Brown ML, Myers EN. Sentinel lymph node biopsy in head and neck squamous cell carcinoma. Laryngoscope 2002;112:2101-13.
20. Jani AB, Basu A, Heimann R, Hellman S. Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma. Cancer 2003;97:359-66.
21. Su LD, Lowe L, Bradford CR, Yahanda AI, Johnson TM, Sondak VK. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph node. J Am Acad Dermatol 2002;46:661-6.
22. Lens MB, Dawes M, Newton-Bishop JA, Goodacre T. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg 2002;89:1223-7.
23. Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 2002;26:47-55.
24. Sumner WE III, Ross MI, Mansfield PF, Lee JE, Prieto VG, Schacherer CW, et al. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer 2002;95:354-60.
25. Creager AJ, Shiver SA, Shen P, Geisinger KR, Levine EA. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Cancer 2002;95:3016-22.
26. Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol 2002;6:257-64.
27. Cochran AJ, Balda BR, Starz H, Bachter D, Krag DN, Cruse CW, et al. The Augsburg consensus: techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000;89:236-41.
28. Cochran AJ. Melanoma metastases through the lymphatic system. Surg Clin North Am 2000;80:1683-1693.
29. Shidham VB, Qi DY, Acker S, Kampalath B, Chang CC, George V, et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol 2001;25:1039-46.
30. Busam KJ, Jungbluth AA. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 1999;6:12-18.
31. Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota J, Sarlomo-Rikala M. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four melanoma markers. Am J Surg Pathol 2001;25:205-11.
32. Trefzer U, Rietz N, Chen Y, Audring H, Herberth G, Siegel P, et al. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions. Arch Dermatol Res 2000;292:583-9.
33. Baisden BL, Askin FB, Lange JR, Westra WH. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol 2000;24:1140-6.